Growth hormone replacement therapy for NASH patients due to adult pituitary gland hyposecretion

Growth hormone replacement therapy for NASH patients due to adult pituitary gland hyposecretion - GLSG,2006,GH

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000642

Enrollment

Registered

2013-12-31

Start date

2006-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Alcoholic steatohepatitis

Interventions

Growth hormone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult pituitary gland hyposecretion NASH

Exclusion criteria

Exclusion criteria: Diabetes Mellitus Complication of malignancy During pregnancy and possibility of pregnancy Participating in the other clinical trials

Design outcomes

Primary

Measure	Time frame
liver histology	—

Secondary

Measure	Time frame
transaminase CT value insulin resistance	—

Countries

Japan

Contacts

Public ContactKen Sato

Gunma University Graduate School of Medicine Department of Medicine and Molecular Science

satoken@showa.gunma-u.ac.jp027-220-8127

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026